We found that in patients with axillary lymph node metastases (n = 74) that FOXP3 and CCL20 expression was correlated with survival: Patients with high CCL20 and FOXP3 expression had a shorter OS (P = .01; P < .001, Fig. 3A, C). Here, FOXP3 is linked to metastatic malignant neoplasm in the lymph nodes.